BioStem Technologies, Inc.
POMPANO BEACH, FL · CIK 0001658678 · Medtech · Public
Perinatal tissue-based allografts for wound healing and regeneration
biostemtechnologies.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $2.7M
- 6 Form D · Sep 2026
- 1 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 19 granted · 21 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2015201720192021202320252027
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $6,000,000 | |
| Private capital raised | Form D · SEC | $10,000 | |
| Private capital raised | Form D · SEC | $3,000,000 | |
| Private capital raised | Form D · SEC | $220,002 | |
| Private capital raised | Form D · SEC | $2,500,000 | |
| Private capital raised | Form D · SEC | $40,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1598 | FirstVitals Inc. | — | $250K |
| 1599 | DIADEM US, INC. | — | — |
| 1600 | FITOTO TECHNOLOGIES INC. | — | — |
| 1601 | BioStem Technologies, Inc. | — | $2.7M |
| 1602 | MADISON SCIENTIFIC, INC. | — | $4.1M |
| 1603 | UNPLUGS HEARING, INC. | — | $225K |
| 1604 | HILLMED INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Patrick DalyDirector
- Thomas DuganDirector
- Katherine GorrellExecutive Officer
- Barry HassettExecutive Officer
- Jason MatuszewskiDirector · Executive Officer
- Brandon PoeExecutive Officer
- Andrew Smith-Van VurstDirector · Executive Officer
- Jodi UngrodtDirector
- Andrew VanVurstDirector · Executive Officer
- Henry VanVurstDirector · Executive Officer
- Andrew Van VurstDirector · Executive Officer
- Kenneth WarringtonDirector
- Robert WatsonDirector
Patents
- Fenestrated Human Placental Allograftgranted
- Fenestrated Human Placental Allograftgranted
- Fenestrated Human Placental Allograftgranted
- Fenestrated Human Placental Allograftgranted
- Fenestrated Human Placental Allograftgranted
- Fenestrated Human Placental Allograftgranted
- Fenestrated Human Placental Allograftgranted
- Fenestrated Human Placental Allograftgranted
- Fenestrated Human Placental Allograftgranted
- Fenestrated Human Placental Allograftgranted
- Sterile Human Placental Allografts And Methods Of Making Thereofgranted
- Micronized Compositions For Wound Healing Prepared From Intact Human Amnion-chorion Tissue Having An Intact Intermediate Spongy Layer Positioned There Betweenapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.